|
|
Volumn 56, Issue 9, 2001, Pages 1249-1250
|
|
Worsening of motor function in Parkinson's disease: A "typical" response to "atypical" antipsychotic medications [3] (multiple letters)
a a a a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIPARKINSON AGENT;
CLOZAPINE;
RISPERIDONE;
ADULT;
AGED;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG BLOOD LEVEL;
DRUG EFFICACY;
DRUG TOLERABILITY;
EXTRAPYRAMIDAL SYMPTOM;
HUMAN;
HUMAN CELL;
HUMAN TISSUE;
LETTER;
MOTOR DYSFUNCTION;
NEGATIVE SYNDROME;
PARKINSON DISEASE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
|
|
EID: 0035826848
PISSN: 00283878
EISSN: None
Source Type: Journal
DOI: 10.1212/WNL.56.9.1249-a Document Type: Letter |
|
Times cited : (3)
|
|
References (0)
|